CourMed Founder/CEO (Derrick L. Miles) provided insight for this recent article from Florida Phoenix.
BY: ISSAC MORGAN – SEPTEMBER 15, 2021 7:13 PM
In Florida’s state capital, the supply of monoclonal antibody therapy appears to be adequate to treat more COVID-19 patients, but shortages elsewhere could be cause for concern as demand rises for the treatments.
For weeks now, Gov. Ron DeSantis has been traversing the state to tout the effectiveness of the therapy, and at least 25 state-supported Regeneron sites have opened in Florida at no cost to patients. The governor’s press conferences usually have included life-saving stories from residents who were ill and got the antibody treatment.
Jill McElwee, incident manager of an antibody site in Leon County, told the Florida Phoenix that the clinic has plenty of doses available for patients and it has been highly effective for people battling COVID.
The Leon County Regeneron site is located at the Governor’s Square Mall in Tallahassee.
“It [a shortage] has not hit us yet,” said McElwee, who is also a registered nurse. “I have Regeneron. I just need people to know that we are here. We are really hearing some positive feedback.”
The U.S. Department of Health and Human Services recently made an announcement about taking over distribution of the antibody therapy at least temporarily, according to The Washington Post. The Post reported that seven states including Florida “have been using 70 percent of the national supply.”
Those other states include Alabama, Texas, Mississippi, Tennessee, Georgia and Louisiana, according the Post.
Like our LinkedIn page to get CourMed updates!
